MÜSKÜLER VENTRİKÜLER SEPTAL DEFEKTİN AMPLATZER DUKTAL OKLÜDER II İLE TRANSKATETER KAPATILMASI

Ventriküler septal defektler transkateter tedavide kapatılması gereken bir defekt olarak görülmektedir. Son yıllarda yeni cihazların bulunması ile birçok merkezde ventriküler septal defektlerin perkütan kapatılması cesaretlendiren sonuçlarla uygulanmaktadır. Amplatzer oklüder sistemlerin son yıllarda kullanılmaya başlaması ile birlikte implantasyon sayılarında artma olmuştur. Bunun yanısıra, müsküler ventriküler septal defektlerin kapatılmasında birkaç cihaz kullanılabilmektedir. Bu yazıda 4 yaşında bir çocukta müsküler outlet ventriküler septal defektin Amplatzer Duktus Oklüder II ile başarılı bir şekilde kapatılmasını bildirmek istedik

Transcatheter Closure of a Muscular Ventricular Septal Defect By Amplatzer Ductal Occluder Ii

Ventricular septal defect has been targeted as a defect to close with transcatheter methods. In recent years with the advent of new devices percutaneous closure of ventricular septal defect has been used in many centers with encouraging results. Introduction of Amplatzer occluder devices has been resulted in increase the number of implants in recent years. Beside this, a few devices can be used for transcatheter closure of muscular ventricular septal defects. We report a successful transcatheter closure of muscular outlet ventricular septal defect in a 4 years of age child with Amplatzer Ductal Occluder II

Keywords:

muscular ventricular septal defect transcatheter closure, amplatzer duct occluder II,

PDF

___

Lewis DA, Loffredo CA, Corre-Villasenor A, Wilson PD, Martin GR. Descriptive epidemiology of membranous and muscular ventricular septal defects I the Baltimore-Washington infant study. Cardiol Young 1996; 6: 281-90.

Shirali GS, Smith EO, Geva T. Quantitation of echocardiographic predictors of outcome in infants with isolated ventricular septal defect. Am Heart J 1995;130: 1228-35.

Porstmann W, Wierny L, Warnke H. Der Verschluss des Ductus arteriousus persistents ohne Thoracotomie. Thoraxchirurgies 1967; 15: 199-203.

Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 1988; 78: 361-368.

Bridges ND, Perry SB, Keane JE, et al. Preoperative transcatheter closure of congenital muscular ventricular septal defects. N Engl J Med 1991; 324: 1312-17.

Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defect occluder: Initial clinical application in children. J Am Coll Cardiol 1999; 33: 1395-99.

Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the Amplatzer Muscular VSD Occluder: Initial results and technical considerations. Cathet Cardiovasc Interv 2000;49:167-72.

Wollenek G, Wyse R, Sullivan I, Elliott M, de Leval M, Stark J. Closure of muscular ventricular septal defects through a left ventriculotomy. Eur J Cardiothorac Surg 1996;10:595-8.

Stellin G, Padalino M, Milanesi O, et al. Surgical closure of apical ventricular septal defects through a right ventricular apical infundibulotomy. Ann Thorac Surg 2000;69:597–601.

Holzer R, Balzer D, cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder. J Am Coll Cardiol 2004; 43: 1257-63.

Celiker A, Ozkutlu S, Karagöz T, Erdoğan I, Ozer S, Aypar E. Device closure of congenital ventricular septal defects with Amplatzer devices: first experiences in Turkey. Turk J Pediatr 2008; 50: 106-13.

Thanopoulos B, Eleftherakis N, Tzannos K, Stefanadis C. Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children. Am Heart J 2008; 156:917.e1-917.e6.

Thanopoulos BV, Tzannos KA, Eleptherakis N, Stefanadis C. Comparison and results of transcatheter closure of patent ductus arteriosus using the swivel-disk device versus plug occluder in children. Am J Cardiol 2008; 102: 486-90.